The self-renewal, growth, and invasion capacity of CSCs can drive malignant transformation [32], thus ENO1-mediated enhancement of these aggressive phenotypes of LCSCs would promote the lung cancer progression. The gene discussed is ENO1; the disease is lung cancer.